Benutzer:Daxpert/Ulf Mark Schneider
Ulf Mark Schneider (born September 9, 1965) is the current CEO of Fresenius SE, a $17 billion global health care group.[1]
Life and career
Schneider was born and raised in Germany and became a U.S. citizen in 2003. He holds a doctorate in economics from the University of St. Gallen, Switzerland, and an MBA from Harvard Business School.[2] Schneider joined Fresenius in November 2001 and served as Chief Financial Officer of Fresenius Medical Care before assuming his current position in May, 2003. Previously, he was Group Finance Director for Gehe UK plc., a pharmaceutical wholesale and retail distributor, in Coventry, England. Schneider held several senior executive positions since 1989 with Gehe’s majority shareholder,, a diversified German industrial company.[3] Under his leadership, Fresenius has nearly doubled its revenues and increased net income more than fourfold. The management challenges of global growth and future strategies in the health care and pharmaceutical industries are of particular interest to Schneider.[4][5][6]
Schneider serves on the board of, a not-for profit hospital in Frankfurt/Germany, and chairs the European Advisory Board of Harvard Business School.
References
- ↑ Business Week: The World’s Best Companies 2009
- ↑ Ulf Mark Schneider’s CV on Fresenius SE´s corporate website
- ↑ Business Week: New Blood Invigorates Dialysis Company
- ↑ St. Gallen Symposium 2006
- ↑ Business Week: A Prescription for Saving Big Drugmakers
- ↑ Harvard Business School case study: Growth and Profitability at Fresenius
External links
{{DEFAULTSORT:Schneider, Ulf Mark}} [[Category:1965 births]] [[Category:Chief executives]] [[Category:Harvard Business School alumni]] [[Category:Living people]]
